In nearly every major chronic condition, medicine accepts that sex differences shape disease. Diagnostic guidelines, risk models, and treatment pathways reflect that reality. Sleep medicine is the exception. Women’s physiology and lived experience are still filtered through male-centered frameworks, which means women’s obstructive sleep apnea (OSA) and insomnia are routinely undiagnosed, misdiagnosed, and suboptimally treated.1
Most core sleep guidelines still mirror male phenotypes. Classic OSA symptom checklists highlight loud snoring, witnessed apneas, and “typical” sleepiness. Yet many women present with fatigue, mood changes, morning headaches, or insomnia rather than the textbook profile.2 They may describe tiredness, fatigue, or low energy instead of sleepiness, which leads to lower scores on the Epworth Sleepiness Scale and a systematic underestimation of risk.3 This can also lead to misdiagnosis and treatment for conditions such as depression, anxiety or insomnia rather than OSA.
Well-documented sex differences in onset, risk factors and chronicity seldom translate into practice-ready guidance. Without female-specific tools and clinical suspicion, clinicians default to templates that underestimate risk, delay referral and overlook how hormonal fluctuation and transitions shape physiology, sleep architecture, and symptom expression.
This means that many women remain largely invisible in the OSA diagnostic net.
How this impacts care at the clinical level
The lack of female-centered guidelines affects clinicians in several ways.
- Delayed or missed diagnosis
Women’s symptoms of fatigue, mood changes, poor concentration, and headaches are often coded as anxiety, depression, or unexplained insomnia. They move through primary and specialty care on antidepressants, sedatives, or pain medications while sleep-disordered breathing remains unrecognized as a core driver.
- Incomplete management lens
Pregnancy, perimenopause, and menopause shape sleep physiology, yet care pathways rarely account for these hormonal transitions.
- Lower guideline alignment When guidelines do not reflect female-specific evidence, they weaken clinician confidence, reduce consistency in care, and reinforce outdated models of disease.
Clinicians want to connect the dots, but the tools they rely on are not built for the patterns observed in women. It is a system design problem, not a clinician motivation problem.
The system-level cost of getting women’s sleep wrong
Unrecognized severe OSA and chronic insomnia in women drive higher rates of hypertension, atrial fibrillation, stroke, diabetes, and depression.1 These conditions commonly trigger emergency visits, unplanned admissions and complex multimorbidity that are costly to manage and difficult to coordinate.
Overall, untreated sleep disorders lead to higher healthcare resource utilization and burden on public funds.4 When diagnostic criteria are poorly calibrated for women, the system pays downstream, repeatedly, for complications that could have been mitigated upstream.
What female-specific sleep guidelines must do
The solution goes beyond cosmetic language about “considering sex.” It is a fundamental redesign of how guidelines are structured, written and operationalized. Female-specific guidelines, or at minimum, robust sex-specific sections within core guidelines, should:
- Define sex-sensitive case-finding
Include explicit screening prompts for key life stages such as pregnancy, postpartum, perimenopause and post-menopause. Identify symptom clusters that should trigger evaluation even when classic “male” symptoms like loud snoring or observed apneas are absent.
- Integrate hormonal transitions into risk stratification
Recognize that shifting complaints during hormonal transitions can signal evolving sleep pathology.
- Specify diagnostic nuances
Acknowledge that women can have clinically meaningful OSA that doesn’t show up as “severe” under male-based scoring systems especially in pre-menopausal women when REM-predominant OSA is more common.5
- Address treatment personalization and adherence
Recommendations for tailoring PAP, oral appliance therapy and behavioral interventions to sleep patterns and lifestyles shaped by caregiving loads, fragmented sleep windows, and shift work.
Clinical Leaders have a vital role to play
Clinicians, researchers, and educators are the fulcrum for change. Without practical actions in that dimension, female-specific guidance remains a theoretical idea rather than standard practice. These include:
- Advocating for research studies that stratify by sex and examine hormonal status as a variable, not a confounder.
- Using societies, CME platforms and guideline committees to move female-specific evidence from appendix to core recommendations and algorithms.
- Training clinicians to recognize women’s sleep complaints as potential indicators of underlying sleep disorders that may carry wider health implications.
By reframing women’s sleep as a clinical priority, leaders can redefine what “standard care” means across networks. When guidelines reflect women’s physiology, sleep complaints become actionable signals rather than misdirections or diagnostic dead ends, and clinicians gain clearer pathways, greater confidence, and better outcomes for half the population they serve.
One-size-fits-all fails women
The absence of female-specific sleep guidelines is not a minor oversight. It is an active driver of inequity and ineffective care for women. Continuing to apply male-derived templates to women’s OSA and insomnia ensures persistent underdiagnosis, avoidable morbidity, and rising system costs.6
Sleep medicine must accelerate toward personalized, whole-person, sex and gender-responsive care. Other chronic disease fields have already accepted that women cannot be treated as an afterthought. The next generation of sleep guidelines must make women visible at every step: in risk stratification, diagnostics, treatment, and implementation.
Anything less is no longer acceptable.
